超声引导下经皮自体肾穿刺活检后显著出血事件相关危险因素:2204例回顾性分析
单中心回顾性分析2005年9月至2015年12月2204例超声引导下经皮自体肾核心穿刺活检,采用18G弹簧驱动活检装置,按CTCAE 4.0定义出血并发症。CTCAE 3级及以上出血发生率为1.64%(37例),病理取材不足率为1.1%。出血风险增加与女性、血小板计数较低、eGFR低于60及穿刺针数≥4次相关;BMI≥25的女性出血风险降低,术前10天内使用阿司匹林(81 mg或325 mg)与出血无显著关联。
要点
- 超声引导下自体肾活检显著出血(CTCAE≥3级)发生率为1.64%,取材不足率仅1.1%。
- 血小板计数>100×10⁹/L与出血风险降低显著相关(p<0.001)。
- 穿刺针数≥4次与出血风险增加显著相关(p=0.012)。
核心结论
- 超声引导下自体肾核心穿刺活检使用18G弹簧驱动装置安全,显著出血并发症发生率低、组织取材充分率高;出血风险增加的相关因素包括女性、血小板计数较低、eGFR降低及穿刺针数≥4次,其中穿刺针数≥4次此前未见报道。
研究设计与样本
- 单中心回顾性研究,纳入2005年9月至2015年12月在本机构行超声引导下经皮自体肾核心穿刺活检的2204例,采用标准化技术及18G弹簧驱动活检装置,出血并发症按美国国立卫生研究院CTCAE 4.0版定义。
诊断标准与关键数值
- 出血并发症定义采用美国国立卫生研究院CTCAE 4.0版,显著出血为CTCAE 3级或以上;2204例中37例(1.64%)发生CTCAE 3级或以上出血;病理报告取材不足率为1.1%;eGFR<60与出血风险显著相关(p=0.025);血小板计数>100×10⁹/L与出血风险降低显著相关(p<0.001);穿刺针数≥4次与出血风险显著相关(p=0.012);女性与出血风险增加相关(p=0.05);女性BMI≥25与出血风险降低相关(p=0.034)。
临床应用与阅片要点
- 使用18G弹簧驱动活检装置行超声引导下自体肾活检时,应关注女性、血小板计数较低、eGFR<60及穿刺针数≥4次等出血风险增加的相关因素;术前10天内使用阿司匹林(81 mg或325 mg)未显示与出血显著相关;作者指出近期阿司匹林治疗与出血的关系尚待明确,超重或肥胖女性出血风险降低的统计学显著意义需进一步研究。
局限性
- 原文结论指出,近期阿司匹林治疗与出血的关系尚未明确;超重或肥胖女性出血并发症风险统计学显著降低需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To review the incidence of significant bleeding complications after ultrasound-guided percutaneous core native renal biopsies at a single center using a standardized technique.
MATERIALS AND METHODS: A retrospective review of ultrasound (US)-guided percutaneous native renal core biopsies done at our institution from September 2005 to December 2015 was performed. Demographic and clinical data were collected at the time of biopsy, with additional clinical information recorded 24 h and 3 months after the biopsy. Bleeding complications were defined using the Common Terminology Criteria for Adverse Events (CTCAE, version 4.0) created by the National Institutes of Health.
RESULTS: 2204 US-guided native renal core biopsies were performed during the study period, with 37 hemorrhages (1.64%) that were CTCAE grade 3 or higher. The rate of inadequate sampling as reported by pathology was extremely low (1.1%). Factors demonstrating a significant association with bleeding risk included estimated glomerular filtration rate (eGFR), specifically when the eGFR was less than 60 (p = 0.025), platelet count (p = 0.002), including a statistically significant decreased risk of bleeding with a platelet count greater than 100 (109/L) (p = <0.001), and performing four or more needle passes (p = 0.012). While female gender was also associated with an increased bleeding risk (p = 0.05), there was a significant association between females with a BMI ≥ 25 and a decreased bleeding risk (0.034). No statistically significant association between post-biopsy hemorrhage and aspirin use within 10 days prior to biopsy or a prior diagnosis of amyloidosis was demonstrated.
CONCLUSION: US-guided native renal biopsy is a safe procedure with a low rate of significant bleeding complications and a high tissue adequacy rate using an 18-gage spring-loaded biopsy device. Factors associated with increased bleeding risk include female gender, lower platelet counts, decreased eGFR and performing four or more needle passes, which has not been reported previously. Interestingly, females with a BMI ≥ to 25 demonstrated a decreased bleeding risk, and aspirin (81 mg or 325 mg) within 10 days of the procedure did not demonstrate a significant effect. While not shown in this current study, the relationship of very recent aspirin therapy with bleeding is yet to be defined. Similarly, the statistically significant decreased risk of bleeding complications in overweight or obese females requires further investigation.
引用
- Monahan H, Gunderson T, Greene E, et al. Risk factors associated with significant bleeding events after ultrasound-guided percutaneous native renal biopsies: a review of 2204 cases. Abdom Radiol (NY). 2019. PMID: 30830293. doi:10.1007/s00261-019-01962-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。